Health EquityMedical OncologyPalliative Care
Dr. Mabel A. Mardones, MD
NPI1134446461PAC ID6305069980
- Medicare services, 2024
- 42,903
- Medicare patients, 2024
- 707
- Part D claims, 2024
- 1,144
- Publications
- 5
- Clinical trials
- 4
- Practice address
- 10107 Ridgegate Pkwy, Lone Tree, CO 80124
- Practice phone
- Call (303) 930-7800
- Professional email
- Get professional email
- Personal email
- Get personal email
- Mobile number
- Get mobile number
Primary practice
Rocky Mountain Cancer Centers
Lone Tree, Colorado
Find Dr. Mardones' professional email, personal email and mobile number
Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.
Dr. Mabel A. Mardones is a hematologist and oncologist in Lone Tree, Colorado
Dr. Mardones practices at Rocky Mountain Cancer Centers in Lone Tree, Colorado.
Dr. Mardones' NPI, 1134446461, was assigned on April 26, 2010. Dr. Mardones graduated from Loma Linda University School of Medicine in 2010. Dr. Mardones holds Colorado license DR.0060709.
NPI and contact details
- NPI
- 1134446461NPI Registry (opens in a new tab)
- Medicare PAC ID
- 6305069980
- NPI enumeration date
- April 26, 2010
- NPI status
- Active
- Accepts Medicare assignment
- Yes
- Offers telehealth
- Yes
- Practice phone
- (303) 930-7800
- Professional email
- Get email
- Personal email
- Get email
- Mobile number
- Get number
- Sex
- Female
- Estimated age
- 42
- Medical school graduation
- 2010
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Practice Data; and Doctors and Clinicians National Downloadable File (CMS)
Dr. Mabel A. Mardones practices at Rocky Mountain Cancer Centers in Lone Tree, Colorado
Dr. Mardones' primary practice is Rocky Mountain Cancer Centers, at 10107 Ridgegate Pkwy, Lone Tree, CO 80124 in Douglas County. The practice phone is (303) 930-7800.
- Rocky Mountain Cancer Centers10107 Ridgegate Pkwy, Lone Tree, CO 80124 · Douglas CountyPhone(303) 930-7800
Sources: NPPES NPI Registry (CMS); and Dmand AI Practice Data
Dr. Mabel A. Mardones is affiliated with 6 sites of care and 1 medical group
Dr. Mardones' primary practice is Rocky Mountain Cancer Centers in Lone Tree, Colorado. Dr. Mardones is also affiliated with HCA HealthONE Sky Ridge. The medical group on file is Rocky Mountain Cancer Centers. Dmand AI also links Dr. Mardones to 4 more hospitals, each named with a free account.
Rocky Mountain Cancer CentersPrimary
Sources: NPPES NPI Registry (CMS); Dmand AI Practice Data; Dmand AI Affiliation Data; and Dmand AI Org Hierarchy Data
Dmand AI tracks the EHR system at Dr. Mabel A. Mardones' practice
Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Mardones practices, 5 sites in all. Vendor and product names are available with a free account.
| Site | EHR vendor and product |
|---|---|
| Rocky Mountain Cancer Centers | Available with a free account |
| +5 more affiliated sites | Available with a free account |
Source: Dmand AI Technology Install Data
For health IT teams
See the EHR and IT leaders at every site where Dr. Mardones practices
Dmand AI maps EHR vendors, IT decision makers and buying committees across each health system and 6.2K+ hospitals, with verified contacts in the same login.
Dr. Mabel A. Mardones is one of 179 hematologists and oncologists in Colorado
Hematology and oncology is Dr. Mardones' primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dmand AI has Dr. Mardones' licenses on file in 2 states: Colorado and Texas.
Specialties and state licenses
- Hematology and oncology, ColoradoPrimary
- Internal medicine, Texas
Hematologists and oncologists near Dr. Mardones
Counts of hematologists and oncologists with a Dmand AI profile, by place and practice. Each opens the list.
179hematologists and oncologists in Colorado
9hematologists and oncologists in Lone Tree
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks
Dr. Mabel A. Mardones billed Medicare for 42,903 services in 2024
CMS data shows 42,903 Medicare services from Dr. Mardones across 47 procedure codes in 2024, for 707 Medicare patients. Medicare paid $1,161,783 for them.
Medicare services, 202442,903
Medicare patients707
Paid by Medicare$1.2M
Procedure codes47
Dr. Mardones' Medicare services by type, 2023 to 2024
- 2023
- 2024
- Drugs given in the office
- 2023: 26,2152024: 36,82040%
- Lab and pathology
- 2023: 3,0142024: 3,001No change
- Tests and treatments
- 2023: 1,0512024: 1,46139%
- Surgery
- 2023: 5952024: 5694%
- Office and hospital visits
- 2023: 4172024: 55232%
- Other services
- 2023: 4412024: 35919%
- Imaging
- 2023: 742024: 14191%
Where Dr. Mardones' Medicare services took place, 2024
- In an office42,851100%
- In a facility520%
Dr. Mardones compared with the Colorado median for hematologists and oncologists, 2024
- Dr. Mardones
- Colorado median
- Medicare services
- 42,903vs 62468.8 times
- Medicare patients
- 707vs 2422.9 times
- Part D claims
- 939vs 50387% above
Medians across 181 hematologists and oncologists in Colorado with Dmand AI profiles that report each measure.
Dr. Mardones' most billed Medicare procedure codes, 2024
CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.
Need commercial claims for Dr. Mardones?
Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Mardones and other hematologists and oncologists in Colorado.
Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks
Dr. Mabel A. Mardones treated 707 Medicare patients in 2024, average age 74
CMS counts 707 Medicare patients who saw Dr. Mardones in 2024. The largest group is 65 to 74, with 374 patients. 75% of them have cancer, and 61% have high cholesterol. 4% are also on Medicaid. Their average risk score is 1.59, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.
Across all payers, Dmand AI patient panel data puts Dr. Mardones' median patient age at 66, with 92% women.
Medicare patients, 2024707
Average age74
Average risk score1.59
Also on Medicaid4%
Dr. Mardones' Medicare patients by age, 2024
Dr. Mardones' Medicare patients by sex, 2024
- Women55078%
- Men15722%
Chronic conditions among Dr. Mardones' Medicare patients, 2024
- Cancer75%
- High cholesterol61%
- High blood pressure56%
- Arthritis46%
- Mood disorders24%
- Anxiety22%
- Osteoporosis22%
- Depression21%
Share of Medicare patients with each condition. A patient can have several.
Dr. Mardones' patients across all payers
Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.
Patient panel by age, all payers
Median age 66
Patient panel by sex, all payers
- Women92%
- Men8%
Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data
Dr. Mabel A. Mardones wrote 1,144 Medicare Part D claims in 2024
In 2024, Dr. Mardones wrote 1,144 Medicare Part D claims for 257 patients. 91% of them were for generic drugs. CMS names the drug for 939 of them, across 20 drugs with 11 or more claims each, at $625,586 in total drug cost. In 2023, CMS named 803 claims across 13 drugs.
Part D claims, 20241,144
Drugs named by CMS20
Total drug cost$625,586
Part D patients257
Dr. Mardones' Part D claims by kind of drug, 2024
- Generic1,040 claims91%
- Brand-name104 claims9%
Dr. Mardones' most prescribed drugs by claims, 2024
CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.
Drug classes CMS tracks in Dr. Mardones' Part D claims, 2024
- Opioids2%18 of 1,144 claims
- Antibiotics3%32 of 1,144 claims
Share of all Part D claims for each drug class CMS reports on. Classes with no claims are left out.
Part D claims for drugs CMS names, 2023 to 2024
- 2023
- 2024
- Claims for drugs CMS names
- 2023: 8032024: 93917%
Drugs named by CMS: 20 in 2024, 13 in 2023.
Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data
Dr. Mabel A. Mardones scored 76 out of 100 in Medicare's MIPS program for 2024
CMS publishes a Merit-based Incentive Payment System (MIPS) score of 76 out of 100 for Dr. Mardones for performance year 2024, reported as part of a group. Dr. Mardones accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Mardones as offering telehealth.
- Accepts Medicare assignment
- Yes
- Offers telehealth
- Yes
Dr. Mardones' MIPS scores, performance year 2024
- 76of 100Final score
- 71.4of 100Quality
- 40of 100Improvement Activities
Each score is out of 100. The final score weighs the categories CMS scored for this clinician.
Sources: Doctors and Clinicians National Downloadable File (CMS); and Clinician Public Reporting: Overall MIPS Performance (CMS), 2024 data, released September 10, 2026
For MedTech and pharma teams
Find hematologists and oncologists like Dr. Mardones by procedure volume and prescribing
Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.
Dr. Mabel A. Mardones has 5 publications on record
Dmand AI links 5 papers to Dr. Mardones, published from 2023 to 2024. 2024 was the busiest year, with 2. The most frequent topics are Medical Oncology and Palliative Care. Dr. Mardones has published most often in Proc (Bayl Univ Med Cent). Dr. Mardones' most frequent co-authors are John R. Krause, MD, Justin Sanders, MD and Erin R. Alesi, MD.
Papers5
Years published2023 to 2024
Topics Dr. Mardones writes about most
- Medical Oncology
- Palliative Care
Dr. Mardones' most frequent co-authors
Recent publications by Dr. Mardones
Medical OncologyPalliative Care
J Womens Health (Larchmt)
Attitude to HealthBreast NeoplasmsWomen's Health
Proc (Bayl Univ Med Cent)
See who Dr. Mardones researches with
Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Mardones works with, so you can find a warm path to the right hematologists and oncologists.
Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage
Dr. Mabel A. Mardones has worked on 4 clinical trials
Dmand AI links Dr. Mardones to 4 clinical trials, 2 of them phase 2 studies. 1 is still active or recruiting. Conditions studied include Breast Neoplasms, Hereditary Sensory and Autonomic Neuropathies and Neoplasm Metastasis. Eli Lilly and Company sponsors the most, 2. Open Payments lists research payments to Dr. Mardones that name 1 trial.
Conditions in Dr. Mardones' trials
- Breast Neoplasms
- Hereditary Sensory and Autonomic Neuropathies
- Neoplasm Metastasis
- Triple Negative Breast Neoplasms
- Breast Diseases
Investigators on the most trials with Dr. Mardones
- Michael A. Danso, MD3 shared trials
- Nicholette L. Erickson, MD2 shared trials
- Shaachi Gupta, MD2 shared trials
Recent clinical trials with Dr. Mardones
Triple Negative Breast NeoplasmsBreast NeoplasmsSacituzumab Govitecan-hziyTrilaciclib
Hereditary Sensory and Autonomic NeuropathiesPolyneuropathiesAlpelisibDapagliflozinDapagliflozin + metformin XR
Breast NeoplasmsBreast DiseasesAbemaciclibNonsteroidal Aromatase Inhibitor (NSAI)
Abemaciclib (LY2835219) Plus Fulvestrant Compared to Placebo Plus Fulvestrant in Previously Treated Breast Cancer (opens in a new tab)
Active, not recruiting
$29,369 in research paymentsNeoplasm MetastasisNeoplastic ProcessesAbemaciclibFulvestrant
Sources: Open Payments (CMS), 2025 data, released July 7, 2026; Dmand AI Research Linkage; and ClinicalTrials.gov (National Library of Medicine)
Dr. Mabel A. Mardones received $151,149 in industry payments from 2016 to 2025
CMS Open Payments shows 204 general payments to Dr. Mardones from 28 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 56% of the total. Puma Biotechnology, Inc. paid the most, $56,314. It also lists 1 research payment totaling $29,369 in 2022, naming 1 clinical trial.
General payments to Dr. Mardones by program year, 2016 to 2025
General payments to Dr. Mardones by kind, 2016 to 2025
$151.1Kin total
- Consulting fees$84,76556%
- Speaker and faculty fees$50,66534%
- Travel and lodging$10,2387%
- Food and beverage$5,2343%
- Education$2470%
Companies that paid Dr. Mardones the most, 2016 to 2025
Share is of all general payments to this clinician.
Source: Open Payments (CMS), 2025 data, released July 7, 2026
Dr. Mabel A. Mardones graduated from Loma Linda University School of Medicine
Dr. Mardones graduated from Loma Linda University School of Medicine in 2010.
- Medical school
Source: Dmand AI Professional Profile Data
Sources for Dr. Mabel A. Mardones's profile data
| Data on this page | Source |
|---|---|
| NPI, name, sex, specialty and licenses | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data |
| Practice locations and phone | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Practice Data |
| Primary practice, affiliations and health system | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Practice DataDmand AI Affiliation DataDmand AI Org Hierarchy Data |
| Medicare services and procedure codes | Medicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab) |
| State medians for the same specialty | Dmand AI Peer Benchmarks |
| Medicare patients and the all-payer patient panel | Dmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab) |
| Part D prescribing | Medicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab) |
| MIPS scores, telehealth, assignment and procedure percentiles | Doctors and Clinicians National Downloadable File (CMS) (opens in a new tab)Clinician Public Reporting: Overall MIPS Performance (CMS) (opens in a new tab) |
| Publications, topics and co-authors | PubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage |
| Clinical trials and co-investigators | Dmand AI Research LinkageClinicalTrials.gov (National Library of Medicine) (opens in a new tab) |
| Industry payments | Open Payments (CMS) (opens in a new tab) |
| Training, board certification and memberships | Dmand AI Professional Profile Data |
| EHR at each practice site | Dmand AI Technology Install Data |
| Similar physicians | Dmand AI Affiliation Data |
Data last refreshed October 2026Report an inaccuracyRemove my information
FAQ
Frequently asked questions about Dr. Mabel A. Mardones
Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.
What is Dr. Mabel A. Mardones' NPI number?
Dr. Mabel A. Mardones' NPI number is 1134446461. It was assigned on April 26, 2010, and it is active in the NPI Registry.
What kind of doctor is Dr. Mabel A. Mardones?
Dr. Mabel A. Mardones is a hematologist and oncologist in Lone Tree, Colorado. The primary specialty in the NPI Registry is Hematology & Oncology Physician (taxonomy code 207RH0003X).
Where does Dr. Mabel A. Mardones practice?
Dr. Mardones practices at 10107 Ridgegate Pkwy, Lone Tree, CO 80124. Dr. Mardones' primary practice is Rocky Mountain Cancer Centers in Lone Tree, Colorado. Dmand AI also links Dr. Mardones to 4 hospitals.
What is Dr. Mabel A. Mardones' office phone number?
The practice phone on file for Dr. Mardones is (303) 930-7800.
What is Dr. Mabel A. Mardones' medical license number?
Dr. Mardones holds Colorado license DR.0060709, one of the licenses on file in 2 states.
Which states has Dr. Mabel A. Mardones been licensed in?
Dmand AI has state licenses on file for Dr. Mardones in Colorado and Texas.
Which hospitals is Dr. Mabel A. Mardones affiliated with?
Dr. Mardones is affiliated with HCA HealthONE Sky Ridge. Dmand AI links Dr. Mardones to 4 more hospitals.
What medical group is Dr. Mabel A. Mardones part of?
Dr. Mardones is linked to Rocky Mountain Cancer Centers.
Does Dr. Mabel A. Mardones accept Medicare?
Yes. CMS data shows Dr. Mardones billed Medicare for 42,903 services in 2024, and Dr. Mardones accepts Medicare assignment.
Does Dr. Mabel A. Mardones offer telehealth?
Yes. The CMS Doctors and Clinicians file lists Dr. Mardones as offering telehealth services.
Show 9 more questionsShow fewer questions
What is Dr. Mabel A. Mardones' MIPS score?
Dr. Mardones' MIPS final score for performance year 2024 is 76 out of 100, reported as part of a group.
How many Medicare patients does Dr. Mabel A. Mardones see?
CMS counts 707 Medicare patients who saw Dr. Mardones in 2024, with an average age of 74.
What services does Dr. Mabel A. Mardones bill to Medicare?
In 2024, Dr. Mardones' most billed Medicare services were injected or infused drug (J9271), injected or infused drug (J9267) and injected or infused drug (J1453).
Where did Dr. Mabel A. Mardones go to medical school?
Dr. Mardones graduated from Loma Linda University School of Medicine in 2010.
What drugs does Dr. Mabel A. Mardones prescribe most?
In 2024 Medicare Part D data, Dr. Mardones' most prescribed drugs by claims were Anastrozole, Tamoxifen Citrate and Letrozole.
Has Dr. Mabel A. Mardones received payments from drug or device companies?
CMS Open Payments shows $151,149 in general payments to Dr. Mardones from 28 companies from 2016 to 2025. The largest total came from Puma Biotechnology, Inc.
How long has Dr. Mabel A. Mardones been practicing?
Dr. Mardones graduated from medical school in 2010, 16 years ago.
Does Dr. Mabel A. Mardones do research?
Dmand AI links 5 publications to Dr. Mardones, published from 2023 to 2024. Dr. Mardones has worked on 4 clinical trials.
Who does Dr. Mabel A. Mardones publish with?
Dr. Mardones' most frequent co-authors are John R. Krause, MD (2 shared papers), Justin Sanders, MD (2 shared papers) and Erin R. Alesi, MD (1 shared paper).
Selling to hematology and oncology practices?
See hematologists and oncologists in Colorado by site of care and group
Find the practices, groups and hospitals they work with, and the right people to contact at each.
- 30 days free
- Self-serve
- No credit card